Luthringer Remy
SEC CIK 1610384 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NERV | Minerva Neurosciences, Inc. | CEO, Dir | 72.6K | — | $105.1K | 2 | 2023-04-28 | 2023-05-01 |
Most active insiders at NERV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Luthringer Remy made no open-market trades at NERV in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-02 | 2023-05-01+ | NERV | Minerva Neurosciences, Inc. | Luthringer Remy | CEO, Dir | S - Sale | $3.84 | -27.4K | 72.6K | -27% | -$105.1K |
| 2023-05-02 | 2023-04-28 | NERV | Minerva Neurosciences, Inc. | Luthringer Remy | CEO, Dir | A - Grant | $0.00 | +88.1K | 96.4K | +1,060% | $0 |
Purchase Sale Sale after option exercise All abbreviations